Cannabis Law Report

DECEMBER 2, 2021

(IGC) is excited to present preliminary positive secondary end point findings from its Phase 1 clinical trial for IGC-AD1. The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021.

Clinical Trials 52

Clinical Trials Data Patients THC 52

Cannabis Law Report

JULY 13, 2022

“Their position as therapeutic practitioners, as well as their work in conducting the kind of clinical trials necessary to advance regulatory outcomes for psychedelic medicines, make them ideal partners in alignment with Optimi’s strategic goals.”.

Therapy 52

Therapy Clinical Trials Microdosing Research and Development 52

The Cannigma

DECEMBER 12, 2022

What is microdosing? A microdose is a dose that does not elicit a perceivable intoxicating or trip-like effect. At most, a mood boost should be all that is felt, and if any visual or auditory effects are noticeable then the dose is not, by definition, a microdose. Everyone is different.

History 119

History Microdosing Research and Development Clinical Trials 119

Canna Law Blog

NOVEMBER 15, 2021

Microdose hosted its annual psychedelics conference in Miami last week (appropriately titled “Wonderland”). Some of these companies are already engaged in clinical trials , a key indicator that significant capital and resources are behind entrants into the market.

Clinical Trials 98

Clinical Trials Treatment Microdosing Pharmaceutical 98

Cannabis Law Report

FEBRUARY 9, 2022

There are also draft rules on how facilitators will be trained to sit with people taking psilocybin to ensure safety. For example, there’s a desire among some people to microdose psilocybin, that is taking very small amounts every few days. Other more complicated issues still need to be decided.

Clinical Trials 52

Clinical Trials Microdosing Safety Conditions 52

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Rick Doblin, Ph.D, in/rickdoblin/ [link]. a leading biotech company in the hemp and cannabis industries. in/ronanlevy/. The Third Wave.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51